Aarkstore.com | West Nile Virus Infections – Pipeline Review, H1 2012 || Market Research

1. Aarkstore.com announces, The Latest market research report is available in
its vast collection:
West Nile Virus Infections – Pipeline Review, H1 2012
You can also request for sample page of above mention reports on
sample@aarkstore.com
Summary
Global Markets Direct’s, West Nile Virus Infections - Pipeline Review, H1 2012,
provides an overview of the West Nile Virus Infections therapeutic pipeline. This
report provides information on the therapeutic development for West Nile Virus
Infections, complete with latest updates, and special features on late-stage and
discontinued projects. It also reviews key players involved in the therapeutic
development for West Nile Virus Infections. West Nile Virus Infections - Pipeline
Review, H1 2012 is built using data and information sourced from Global Markets
Direct’s proprietary databases, Company/University websites, SEC filings, investor
presentations and featured press releases from company/university sites and
industry-specific third party sources, put together by Global Markets Direct’s team.
Note*: Certain sections in the report may be removed or altered based on the
availability and relevance of data for the indicated disease.
Scope
- A snapshot of the global therapeutic scenario for West Nile Virus Infections.
- A review of the West Nile Virus Infections products under development by
companies and universities/research institutes based on information derived from
company and industry-specific sources.
- Coverage of products based on various stages of development ranging from
discovery till registration stages.

2. - A feature on pipeline projects on the basis of monotherapy and combined
therapeutics.
Table of contents:
List of Tables 3
List of Figures 4
Introduction 5
Global Markets Direct Report Coverage 5
West Nile Virus Infections Overview 6
Therapeutics Development 7
An Overview of Pipeline Products for West Nile Virus Infections 7
West Nile Virus Infections Therapeutics under Development by Companies 9
Late Stage Products 10
Comparative Analysis 10
Mid Clinical Stage Products 11
Comparative Analysis 11
Pre-Clinical Stage Products 12
Comparative Analysis 12
West Nile Virus Infections Therapeutics – Products under Development by
Companies 13
Companies Involved in West Nile Virus Infections Therapeutics Development 14
CEL-SCI Corporation 14
Hemispherx Biopharma, Inc. 15
BioMAS Ltd. 16
MacroGenics, Inc. 17
West Nile Virus Infections – Therapeutics Assessment 18
Assessment by Monotherapy Products 18
Assessment by Route of Administration 19
Assessment by Molecule Type 21
Drug Profiles 23
ChimeriVax-West Nile - Drug Profile 23
Product Description 23
Mechanism of Action 23
R&D Progress 23
Alferon N Injection - Drug Profile 24

3. Product Description 24
Mechanism of Action 24
R&D Progress 24
CEL-1000 - Drug Profile 25
Product Description 25
Mechanism of Action 25
R&D Progress 26
AS101 - Drug Profile 28
Product Description 28
Mechanism of Action 28
R&D Progress 28
MGAWN1 - Drug Profile 30
Product Description 30
Mechanism of Action 30
R&D Progress 30
West Nile Virus Infections Therapeutics – Drug Profile Updates 31
West Nile Virus Infections Therapeutics - Dormant Products 32
West Nile Virus Infections – Product Development Milestones 33
Featured News & Press Releases 33
Sep 06, 2011: Hemispherx Enters Into Strategic Alliance With Armada Health Care
For Alferon N Injection 33
Appendix 34
Methodology 34
Coverage 34
Secondary Research 34
Primary Research 34
Expert Panel Validation 34
Contact Us 35
Disclaimer 35
List of Figures
List of Tables are also include.

4. For more related Reports Plz follow The link:
Pipeline Review, H1 2012
http://www.aarkstore.com/search/viewresults.asp?search=Pipeline Review, H1
2012&PubId=&pagenum=1
Tachycardia (Tachyarrhythmias) – Pipeline Review, H1 2012
Genital Warts (Condylomata Acuminata) – Pipeline Review, H1 2012
Gingivitis – Pipeline Review, H1 2012
West Nile Virus Infections – Pipeline Review, H1 2012
Pompe Disease – Pipeline Review, H1 2012
Bronchiolitis Obliterans – Pipeline Review, H1 2012
Cancer Cachexia – Pipeline Review, H1 2012
Hyperuricemia – Pipeline Review, H1 2012
Sarcoidosis – Pipeline Review, H1 2012
Optic Nerve Injury – Pipeline Review, H1 2012
Search More Reports Related to This Category :

5. Pharmaceuticals and Healthcare
http://www.aarkstore.com/search/viewresults.asp?search=Pharmaceuticals and
Healthcare&PubId=&pagenum=1
For More details Plz do contact :
Aarkstore Enterprise
Lavanya
Phone:08149852585
Email: enquiry@aarkstore.com